What is the systematic approach to taking a patient history for suspected infectious diseases?

Systematic Approach to History Taking for Infectious Diseases

A comprehensive infectious disease history must systematically capture timing of infection, exposure risks, medication history, comorbidities, travel/geographic exposures, and social factors to guide diagnosis and prevent life-threatening complications.

Essential Components of the Initial History

Timing and Chronology of Illness

• Document the date of diagnosis and approximate date of infection based on prior negative test results, occurrence of acute symptoms, or timing of high-risk activities 1
• Establish symptom onset relative to potential exposures, as most tropical infections become symptomatic within 21 days of exposure and the majority of febrile returning travelers present within one month of leaving endemic areas 1
• Obtain detailed geographical history including where the patient has traveled and lived, as patients reporting travel in areas of endemicity (e.g., histoplasmosis in Ohio and Mississippi River valleys, coccidioidomycosis in southwestern deserts) may be at risk for reactivation disease even after moving to non-endemic areas 1

Medication and Treatment History

• For patients previously treated, obtain complete antiretroviral or antimicrobial therapy history including drug combinations taken, response to each regimen (CD4 cell count and viral load for HIV), duration of treatment, reasons for treatment changes, drug toxicities, adherence, and prior drug resistance test results 1
• Document all current medications including prescription drugs, over-the-counter medications, methadone, and dietary or herbal supplements, as these may interact with antimicrobial therapies 1
• Inquire about hypersensitivity reactions to prior therapies, including sulfonamides, specific antiretroviral classes, and other antimicrobials 1
• Ask about recent antibiotic use within the previous 2-4 weeks, as this increases risk for resistant organisms including penicillin-resistant Streptococcus pneumoniae 1

Past Medical History and Comorbidities

• Screen for prior HIV-associated complications and opportunistic infections, malignancies, and cardiovascular disease 1
• Document chronic medical conditions such as peripheral neuropathy, gastrointestinal disease, chronic viral hepatitis (hepatitis B and C), hyperlipidemia, diabetes mellitus, renal insufficiency, or COPD, as these affect therapy choice and increase risk of severe infection 1
• Obtain history of chickenpox or shingles, tuberculosis or tuberculosis exposure (including results of tuberculin skin tests), sexually transmitted diseases, and gynecologic problems 1
• Ask about recent hospital admission within the previous year (increases risk for S. pneumoniae, especially penicillin-resistant strains) or within 2-4 weeks (increases risk for gram-negative enteric bacilli) 1
• Document immunization status including tetanus toxoid, pneumococcal vaccine, hepatitis A and B vaccines, and varicella vaccination 1

Social History and Risk Factors

• Conduct detailed substance use assessment including tobacco, alcohol, heroin, and recreational drugs (marijuana, cocaine, MDMA/"ecstasy", ketamine, methamphetamine) 1
• For active injection drug users, ask about drug-use practices, source of needles, and whether they share needles or other drug-injection equipment (syringes, cotton, cooker, water) 1
• Obtain sexual history in an open, nonjudgmental manner asking about past and current practices, number of partners (multiple or anonymous sex partners), sexual practices (including receptive anal sex, receptive oral sex), condom and contraceptive use, and whether partner(s) have been informed of any infectious disease status 1
• Screen for sexually transmitted infections risk factors including past history of any STD, sex or needle-sharing partners with high-risk behaviors, and high prevalence of STDs in the patient's area or population 1

Psychosocial Assessment

• Screen for depression using direct questions or validated screening tools, as depression is common among patients with infectious diseases and twice as high among women with HIV infection 1
• Assess for domestic violence and adult sexual/physical abuse using direct questions or validated screening tools, particularly in women with HIV infection who have high rates of victimization 1
• Document whom the patient has informed of their diagnosis, how they have been coping, what support they are receiving, living situation, housing issues, employment, and family structure 1

Family Medical History

• Obtain family history of conditions predisposing to malignancies, neurologic diseases, osteoporosis, and atherosclerotic disease (hypertension, diabetes mellitus, hyperlipidemia) 1
• Document family history of early coronary heart disease (myocardial infarction in first-degree relative before age 55 years in males, before age 65 years in females) 1
• For children with early-onset disease (under age 5), strongly suspect underlying immune deficiencies 1

Review of Systems for Infectious Diseases

Constitutional and Systemic Symptoms

• Inquire about fever, night sweats, weight loss and compare current weight with baseline 1
• Ask about changes in mood, libido, sleeping patterns, appetite, concentration, and memory to screen for depression 1

Organ System-Specific Symptoms

• Neurological: headaches, visual changes, changes in neurological function or mental status 1
• Head/ENT: anosmia (loss of smell), dysgeusia (taste changes), oral thrush or ulceration, swallowing difficulties 1
• Respiratory: cough, shortness of breath, chest pain 1
• Gastrointestinal: nausea, vomiting, abdominal pain, diarrhea 1
• Genitourinary: urinary symptoms, anogenital symptoms 1
• Dermatologic: skin rashes or lesions, non-blanching petechial or purpuric rash, mottled or ashen appearance 1
• Gynecologic: menstrual history for women 1

Risk Stratification and Severity Assessment

Immediate Assessment for Life-Threatening Illness

• Identify red flags for sepsis or serious illness including mottled or ashen appearance, non-blanching petechial or purpuric rash, cyanosis of skin/lips/tongue 1
• Calculate NEWS2 score (respiratory rate, oxygen saturation, supplemental oxygen requirement, systolic blood pressure, pulse, consciousness level, temperature) to determine risk of severe illness or death from sepsis 1
• Recognize that a score of 3 in any single parameter may indicate increased risk from sepsis, score 5-6 suggests moderate risk, and score ≥7 suggests high risk 1

Age and Vulnerability Factors

• Age >65 years increases risk for Streptococcus pneumoniae and severity of disease 1
• Institutionalized patients are at higher risk for S. pneumoniae, gram-negative enteric bacilli, Staphylococcus aureus, and anaerobic bacteria 1
• Alcoholism increases risk for gram-negative bacilli and Legionella species 1

Common Pitfalls and Caveats

• Do not delay obtaining bacterial blood cultures, sputum, or CSF samples in life-threatening illnesses (septicemia, endocarditis, bacterial meningitis, severe pneumonia) before initiating empiric antibiotic therapy 2
• Avoid relying solely on point-of-care biomarker and microbiological tests to determine care at first presentation 1
• Interpret NEWS2 scores in context of underlying physiology and comorbidities, recognizing that scores may underestimate risk if the patient's condition is deteriorating or has not improved since previous assessment 1
• In less urgent cases, delay antibiotic treatment to diagnose the infection correctly using a multi-step diagnostic approach 2
• Atypical courses must necessitate careful and critical reassessment of the diagnosis 2
• Combining clinical features with epidemiologic clues (exposure to settings with documented disease activity, epidemiologic linkage to other persons with pneumonia, exposure to healthcare settings) provides a strategic framework for early recognition of emerging infections 3